IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

2,327
Mkt Cap
$514.06M
Volume
5.00
52W High
$5.13
52W Low
$0.5271
PE Ratio
21.50
IRWD Fundamentals
Price
$3.32
Prev Close
$3.16
Open
$3.18
50D MA
$1.90
Beta
0.67
Avg. Volume
1.25M
EPS (Annual)
$0.0055
P/B
-2.04
Rev/Employee
$1.39M
Loading...
Loading...
News
all
press releases
LSV Asset Management Sells 1,247,601 Shares of Ironwood Pharmaceuticals, Inc. $IRWD
LSV Asset Management decreased its position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 31.2% during the second quarter, according to its most recent Form 13F filing...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Recommendation of "Hold" by Brokerages
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) has been assigned a consensus rating of "Hold" from the eight analysts that are currently covering the company, MarketBeat reports. One...
MarketBeat·3d ago
News Placeholder
Can Linzess Continue to Aid IRWD's Top Line After a Strong Q3?
Ironwood gains momentum as rising U.S. demand for Linzess drives strong profit growth during the third quarter.
Zacks·4d ago
News Placeholder
Ironwood Pharmaceuticals, Inc. $IRWD Shares Purchased by Los Angeles Capital Management LLC
Los Angeles Capital Management LLC grew its stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 76.1% in the second quarter, according to its most recent 13F filing with the...
MarketBeat·10d ago
News Placeholder
Research Analysts Offer Predictions for IRWD FY2025 Earnings
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Equities researchers at Leerink Partnrs lowered their FY2025 earnings per share estimates for shares of Ironwood Pharmaceuticals in a...
MarketBeat·11d ago
News Placeholder
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 9.2% Following Analyst Upgrade
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 9.2% Following Analyst Upgrade...
MarketBeat·12d ago
News Placeholder
Ironwood Pharmaceuticals (NASDAQ:IRWD) Releases Quarterly Earnings Results, Beats Estimates By $0.15 EPS
Ironwood Pharmaceuticals (NASDAQ:IRWD - Get Free Report) posted its quarterly earnings results on Monday. The biotechnology company reported $0.24 earnings per share for the quarter, beating...
MarketBeat·12d ago
News Placeholder
IRWD Rises 110% in a Month: Should You Buy, Sell or Hold the Stock?
Ironwood's 110% monthly surge follows upbeat third-quarter results and raised 2025 outlook, powered by increasing Linzess demand.
Zacks·12d ago
News Placeholder
Leerink Partnrs Analysts Lift Earnings Estimates for IRWD
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Research analysts at Leerink Partnrs raised their Q2 2026 EPS estimates for shares of Ironwood Pharmaceuticals in a research report issued...
MarketBeat·12d ago
News Placeholder
Ironwood Pharmaceuticals (NASDAQ:IRWD) Price Target Raised to $3.00
Wells Fargo & Company boosted their price target on Ironwood Pharmaceuticals from $1.00 to $3.00 and gave the stock an "equal weight" rating in a research report on Tuesday...
MarketBeat·13d ago

Latest IRWD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.